Ocular TherapeutixvsUnitedHealth

OCUL and UNH stock compared: price, dividend, valuation and results, from SEC filings.

OCUL

Ocular Therapeutix, Inc.

$5.89

Value $1.3B

-0.84%
OCUL's page

UNH

UnitedHealth Group Incorporated

$334.44

Value $304B

-4.47%
UNH's page

Ocular Therapeutix (OCUL) has a market value of $1.3B and UnitedHealth (UNH) $304B. Over the last year, with dividends, OCUL moved -49.9% and UNH +9.4%. Dividend yield: OCUL none, UNH 2.71%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    OCUL$1.3B

    UNH$304B

    UNH is 237 times OCUL

  • Revenue, 12 months

    OCUL$50M

    UNH$450B

    UNH is 8,925 times OCUL

  • Net income, 12 months

    OCUL-$327M

    UNH$15.9B

  • Operating margin

    OCUL-680.9%

    UNH5.3%

    686.2 points apart

  • ROIC

    OCUL-48.1%

    UNH11.3%

    59.4 points apart

  • P/E

    OCUL–

    UNH19.1

  • Dividend yield

    OCUL0.0%

    UNH2.7%

    2.7 points apart

  • 5-year return

    OCUL-12.2%

    UNH-18.6%

    6.4 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

OCUL-12.2%

UNH-18.6%

10020020222023202420252026
Returns by period
PeriodOCULWith dividendsUNHWith dividends
1 year since November 18, 2025-49.9%Price -49.9%+9.4%Price +6.6%
3 years since November 17, 2023+158.3%+37.2% a yearPrice +158.3%-33.6%-12.8% a yearPrice -37.7%
5 years since November 18, 2021-12.2%-2.6% a yearPrice -12.2%-18.6%-4.0% a yearPrice -25.6%
10 years since November 21, 2016-42.1%-5.3% a yearPrice -42.1%+162.4%+10.1% a yearPrice +122.2%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

OCULOcular TherapeutixUNHUnitedHealth

Valuation

OCULUNH
Valuation
Price$5.89$334.44
Market value$1.3B$304B
Enterprise value (EV)–$349B
P/E–19.1
P/E, 5-year median–25.0
P/B2.92.9
EV/EBIT–14.6
Free cash flow yield–7.5%

Results and growth

OCULUNH
Results and growth
Revenue, 12 months$50M$450B
Net income, 12 months-$327M$15.9B
Free cash flow, 12 months-$267M$22.8B
Earnings per share, 12 months-$1.44$17.52
Revenue growth, year on year-18.5%11.8%
Revenue growth a year, past+24.5%over 5 years+11.7%over 5 years
EPS growth a year, past–-3.8%over 5 years

Margins and returns on capital

OCULUNH
Margins and returns on capital
Gross margin87.3%88.3%
Operating margin-680.9%5.3%
Net margin-648.6%3.5%
ROIC-48.1%11.3%
ROE-66.6%15.5%

Balance sheet

OCULUNH
Balance sheet
Cash$531M$28.5B
Total debt–$74.3B
Net debt / EBITDA–1.6
Interest cover-30.6×6.2×

Dividends and buybacks

OCULUNH
Dividends and buybacks
Dividend yield–2.7%
Dividend per share, 12 months–$9.06
Dividend growth a year, past–+12.6%over 5 years
Buyback yield–1.8%
Shareholder yield–4.5%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: OCUL or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, Ocular Therapeutix or UnitedHealth?

By market value, UnitedHealth ($304B) is about 236.8 times Ocular Therapeutix ($1.3B), at today's prices.

How did OCUL and UNH stock do over the last 10 years?

Since November 21, 2016, OCUL's price moved -42.1% and UNH's +122.2%. With dividends: OCUL -42.1% (-5.3% a year), UNH +162.4% (+10.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, OCUL or UNH?

The dividend yield at today's price is none for Ocular Therapeutix and 2.71% for UnitedHealth. Over the last twelve months they paid – and $9.06 per share.

Which has the higher profit margins, Ocular Therapeutix or UnitedHealth?

Over the last twelve months, the net margin was -648.6% for Ocular Therapeutix and 3.5% for UnitedHealth, and the operating margin -680.9% and 5.3%. Revenue was $50M and $450B.

Which is the better investment, Ocular Therapeutix or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.